Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Constitutive activation of metalloproteinase ADAM10 in mantle cell lymphoma promotes cell growth and activates the TNFα/NFκB pathway

Hanan Armanious, Pascal Gelebart, Mona Anand, Andrew Belch, Raymond Lai

Blood (2011) 117 (23): 6237–6246.

https://doi.org/10.1182/blood-2010-10-313940

Published: 2011

Includes: Supplemental data

Journal Articles

Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma

Pascal Gelebart, Mona Anand, Hanan Armanious, Anthea C. Peters, Jennifer Dien Bard, Hesham M. Amin, Raymond Lai

Blood (2008) 112 (13): 5171–5179.

https://doi.org/10.1182/blood-2008-02-139212

Published: 2008

Journal Articles

In vivo kinetics of kinase domain mutations in CML patients treated with dasatinib after failing imatinib

Jamshid S. Khorashad, Dragana Milojkovic, Puja Mehta, Mona Anand, Sara Ghorashian, Alistair G. Reid, Valeria De Melo, Anna Babb, Hugues de Lavallade, Eduardo Olavarria, David Marin, John M. Goldman, Jane F. Apperley, Jaspal S. Kaeda

Blood (2008) 111 (4): 2378–2381.

https://doi.org/10.1182/blood-2007-06-096396

Published: 2008

Journal Articles

Varying response to escalating the dose of imatinib in patients with CML who “acquire” a BCR-ABL M244V mutant allele

Mona Anand, Jamshid Khorashad, David Marin, Jane F. Apperley, John M. Goldman, Jaspal Singh Kaeda

Blood (2006) 108 (8): 2881–2882.

https://doi.org/10.1182/blood-2006-05-020859

Published: 2006

Journal Articles

Varying Response to Imatinib in CML Patients with BCR-ABL M244V Mutation.

Jamshid S. Khorashad, MD, Mona Anand, MD, David Marin, MD, Catharina Andreasson, BSc, Sara Ghorashian, MD, Jane F. Apperley, PhD, John M. Goldman, MD, Jaspal S. Kaeda, PhD

Blood (2005) 106 (11): 1986.

https://doi.org/10.1182/blood.V106.11.1986.1986

Published: 2005

Journal Articles

How Best to Express the Results of Serial RQ-PCR Studies to Measure Minimal Residual Disease in Treated Leukaemia Patients?.

Mona Anand, MD Hammersmith Hos, Jaspal S. Kaeda, PhD Hammersmith Hos, Richard Szydlo, PhD Hammersmith Hos, Jamshid S. Khorshad, MD Hammersmith Hos, David Marin, MD Hammersmith Hos, Bryony Swale, MSc Hammersmith Hos, Sue Saunders, MSc Hammersmith Hos, Eduardo Olavarria, MD Hammersmith Hos, John M. Goldman, MD Hammersmith Hos, Jane F. Apperley, PhD Hammersmith Hos

Blood (2004) 104 (11): 1104.

https://doi.org/10.1182/blood.V104.11.1104.1104

Published: 2004

NARROW

Constitutive activation of metalloproteinase ADAM10 in mantle cell lymphoma promotes cell growth and activates the TNFα/NFκB pathway

Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma

In vivo kinetics of kinase domain mutations in CML patients treated with dasatinib after failing imatinib

Varying response to escalating the dose of imatinib in patients with CML who “acquire” a BCR-ABL M244V mutant allele

Varying Response to Imatinib in CML Patients with BCR-ABL M244V Mutation.

How Best to Express the Results of Serial RQ-PCR Studies to Measure Minimal Residual Disease in Treated Leukaemia Patients?.

Email alerts

ASH Publications

American Society of Hematology

Constitutive activation of metalloproteinase ADAM10 in mantle cell lymphoma promotes cell growth and activates the TNFα/NFκB pathway

Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma

In vivo kinetics of kinase domain mutations in CML patients treated with dasatinib after failing imatinib

Varying response to escalating the dose of imatinib in patients with CML who “acquire” a BCR-ABL M244V mutant allele

Varying Response to Imatinib in CML Patients with BCR-ABL M244V Mutation.

How Best to Express the Results of Serial RQ-PCR Studies to Measure Minimal Residual Disease in Treated Leukaemia Patients?.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only